20 Myths About ADHD Medication Pregnancy: Busted > 자유게시판

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is a challenge for women suffering from the condition. There aren't enough data on how exposure to ADHD for a long time could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological conditions like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should consider the benefits of taking it versus the risks for the baby. The doctors don't have the information to give clear advice, but can provide information on the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based study of case control to assess the frequency of major structural defects in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was accurate and to eliminate any bias.

The study conducted by the researchers was not without its limitations. The researchers were not able to, in the first place to distinguish the effects caused by the medication from the disorder. This makes it difficult for researchers to determine whether the small associations observed among the groups that were exposed to the use of medication, or if they were confounded by co-morbidities. In addition, the researchers did not examine the long-term effects of offspring on their parents.

The study revealed that infants whose mother had taken ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) in comparison to those whose mothers did not take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders and the higher risk of admission was not found to be influenced by which stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications in early pregnancies could be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman's condition. Physicians should talk to their patients about this issue and as much as possible, assist them develop coping strategies that could reduce the effects of her disorder on her daily functioning and her relationships.

Interactions with Medication

Doctors are increasingly faced with the decision of whether to maintain treatment or stop as more women are diagnosed with ADHD. These decisions are frequently made without clear and reliable evidence. Instead, doctors have to consider their own expertise, the experience of other doctors, and the research that has been conducted on the subject.

The issue of potential risks to the infant can be extremely difficult. Many of the studies on this issue are based on observational data rather than controlled research, and their findings are often contradictory. Furthermore, most studies restrict their analysis to live births, which may undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by analyzing data on live and deceased births.

The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link, and most studies show a neutral or even slightly negative impact. As a result, a careful risk/benefit analysis must be done in each instance.

It can be challenging, if not impossible for women with ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can a doctor prescribe adhd medication without a diagnosis lead to depression and feelings of being isolated. A decrease in medication could also affect the ability to safely drive and perform work-related tasks, which are essential aspects of daily life for people with ADHD.

She suggests that women who are unsure about whether to continue or discontinue medication due to their pregnancy, consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily life, and the advantages of continuing the current treatment regimen. It can also aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can be passed through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug could be passed on to her baby.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (adhd without medication) grows there are concerns about what impact the medications could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Researchers used two massive datasets to analyze over 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medications was associated with an increased risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers of the study could not discover any connection between early use of medication and other congenital anomalies, like facial deformities or club feet. The results are consistent with previous studies that have shown the presence of a small, but significant increase in the risk of heart malformations among women who began taking intuitive adhd medication medications prior to the time of pregnancy. This risk increased during the latter part of pregnancy when many women began to stop taking their medication.

Women who used ADHD medication in the first trimester of their pregnancy were also more likely to undergo caesarean sections, a low Apgar score following delivery, and a baby who required breathing assistance during birth. However the authors of the study were not able to eliminate selection bias by restricting the study to women who didn't have any other medical issues that could have contributed to these findings.

The researchers hope their research will aid in the clinical decisions of physicians who see pregnant women. They recommend that, while the discussion of the benefits and risks is important but the decision to stop or keep medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also advise that while discontinuing the medications is an option, it isn't an option to consider due to the high prevalence of depression and other mental health issues in women who are pregnant or who are recently post-partum. Additionally, the research suggests that women who decide to stop taking their medications are more likely to experience difficulties adapting to life without them following the birth of their baby.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments and preparing for the arrival of a child and getting used to new routines at home may face a lot of challenges. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications pass through breast milk in very small amounts, so the risk to the breastfeeding infant is minimal. However, the amount of exposure to medications by the infant can differ based on the dosage, frequency it is administered and the time of day it is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or breast milk. The effect on the health of a newborn is not fully known.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the lack of research. This is a difficult decision for the patient, who must weigh the benefits of continuing her medication against the potential risks to the embryo. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication in a safe manner while breastfeeding and during pregnancy. In response, a rising number of patients are opting to continue their medication. They have found after consulting with their physicians that the benefits of retaining their current medication outweigh any potential risks.

It's important for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including Non prescription adhd medication for adults-pharmacological strategies. Psychoeducation is also required to help pregnant people with ADHD recognize their symptoms and underlying disorder and learn about treatments and to reinforce existing strategies for managing. This should be an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, monitoring of signs of deterioration, and, if needed adjustments to the medication regime.